文献速递糖尿病

年轻起病2型糖尿病亚洲人群糖尿病肾脏病的血浆蛋白质组学研究

Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

在起病年龄<40岁的2型糖尿病(YT2D)患者中,144例糖尿病肾脏病(DKD)进展者与292例非进展者按起病年龄、性别和种族匹配。采用邻近延伸分析技术检测1472种血浆蛋白,多变量逻辑回归和孟德尔随机化分析发现42种蛋白与DKD进展相关,血管生成素为最强信号之一(OR=5.29,95%CI 2.39-11.73,P=4.03×10⁻⁵),遗传证据提示其可能具有因果作用。

要点

  • 在YT2D中,42种血浆蛋白与DKD进展相关,独立于传统心肾危险因素、基线eGFR和尿白蛋白肌酐比值。
  • 血管生成素为最强信号之一(OR=5.29,95%CI 2.39-11.73,P=4.03×10⁻⁵)。
  • 遗传决定的血浆血管生成素水平与DKD进展风险增加相关,提示可能因果作用。

核心结论

  • 大规模蛋白质组学分析识别了YT2D中DKD进展的新蛋白质组生物标志物,遗传证据提示血浆血管生成素在DKD进展中可能具有因果作用。

研究设计与样本

  • 在起病年龄<40岁的YT2D患者中,144例DKD进展者(病例)按起病年龄、性别和种族与292例非进展者(对照)匹配,分为发现集和验证集。
  • DKD进展定义为估算肾小球滤过率(eGFR)较基线下降≥3 mL/min/1.73 m²或eGFR下降≥40%。
  • 采用基于邻近延伸分析技术的多重免疫分析检测1472种血浆蛋白,多变量逻辑回归识别与DKD进展相关的蛋白,孟德尔随机化评估因果关系。

主要发现

  • 42种血浆蛋白与DKD进展相关,独立于传统心肾危险因素、基线eGFR和尿白蛋白肌酐比值。
  • 识别的蛋白涉及炎症和重塑生物学过程。
  • 血管生成素为最强信号之一(OR=5.29;95%CI 2.39-11.73;P=4.03×10⁻⁵)。
  • 遗传决定的血浆血管生成素水平与DKD进展风险增加相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Patients with younger onset of type 2 diabetes (YT2D) have increased risk for kidney failure compared to those with late onset. However, the mechanism of diabetic kidney disease (DKD) progression in this high-risk group is poorly understood. OBJECTIVE: This work aimed to identify novel biomarkers and potential causal proteins associated with DKD progression in patients with YT2D. METHODS: Among YT2D (T2D onset age <40 years), 144 DKD progressors (cases) were matched for T2D onset age, sex, and ethnicity with 292 nonprogressors (controls) and divided into discovery and validation sets. DKD progression was defined as decline of estimated glomerular filtration rate (eGFR) of 3 mL/min/1.73 m2 or greater or 40% decline in eGFR from baseline. A total of 1472 plasma proteins were measured through a multiplex immunoassay that uses a proximity extension assay technology. Multivariable logistic regression was used to identify proteins associated with DKD progression. Mendelian randomization (MR) was used to evaluate causal relationship between plasma proteins and DKD progression. RESULTS: Forty-two plasma proteins were associated with DKD progression, independent of traditional cardiorenal risk factors, baseline eGFR, and urine albumin-to-creatinine ratio. The proteins identified were related to inflammatory and remodeling biological processes. Our findings suggest angiogenin as one of the top signals (odds ratio = 5.29; 95% CI, 2.39-11.73; P = 4.03 × 10-5). Furthermore, genetically determined plasma angiogenin level was associated with increased odds of DKD progression. CONCLUSION: Large-scale proteomic analysis identified novel proteomic biomarkers for DKD progression in YT2D. Genetic evidence suggest a causal role of plasma angiogenin in DKD progression.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Gurung RL, Zheng H, Koh HWL, et al. Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 Diabetes. J Clin Endocrinol Metab. 2025. PMID: 38626182. doi:10.1210/clinem/dgae266

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。